CDH Fund IV

CDH Fund IV is a private equity fund managed by CDH Investments, a firm established in 2002 and based in Beijing, China. The fund focuses on investments within China, particularly in the healthcare, business-to-consumer (B2C), and information technology sectors. CDH Investments has built a diversified alternative asset management platform, encompassing private equity, venture capital, growth capital, real estate, and more. The firm is known for its commitment to fostering long-term partnerships with global investors and portfolio companies, leveraging its experienced team to identify and capitalize on investment opportunities across various stages of the corporate lifecycle. By concentrating on industries such as healthcare and technology, CDH Fund IV aims to generate significant returns while aligning with market trends and consumer demands.

Niles Ho

VP

Xinquan Lin

VP

Yuanxi Tian

Investment Manager

Helen Tian

Financial Controller

Wang Lin Ph.D

Co-Founder & Managing Partner, Venture and Growth Capital

Wei Ying

Managing Partner

Jiao Zhen

CEO

Past deals in Eastern Asia

Ai Ma Biology

Angel Round in 2023
Ai Ma Biology is a small RNA nucleic acid drug developer, dedicated to the transformation of achievements in the field of biosynthesis.

Keyang Semiconductor

Venture Round in 2023
Keyang is mainly engaged in the design, R&D, manufacture, packaging, and testing of semiconductor TSV package integrated circuit products.

Qingxin Technology

Series A in 2022
Zhejiang Qingxin is a manufacturer of semiconductor testing and sorting machines. It is involved in the research, development, and manufacture of most semiconductor automation equipment, with a focus on testing and packaging handling solutions.

Style3D

Series B in 2022
Shanghai Linctex Digital Co., Ltd. specializes in software solutions for the fashion industry, focusing on three-dimensional (3D) design and collaboration. Founded in 2015 and based in Shanghai, the company offers a suite of services under the brand Style3D, which includes 3D modeling, physical simulation, and rendering tools tailored for fashion workflows. Their offerings encompass various functionalities such as three-dimensional pattern checking, component-based design, style management, and online style recommendations. Additionally, Linctex provides product data management solutions that facilitate resource accumulation, cost accounting, and bill of materials generation. The company also supports fabric sales and exhibitions through 3D displays and mobile sharing capabilities, all powered by online cloud services. Linctex aims to empower small and medium-sized clothing enterprises with innovative tools to enhance their design and production processes.

TSC

Venture Round in 2022
TSC Laser Technology Development (Beijing) Co., Ltd. provides 3D printing services. The firm is headquartered in China.

Qingyun Zhitong

Series B in 2022
Qingyun Zhitong is an intelligent manufacturing enabling enterprise in the chemical industry. It is a continuous transformation platform for the scientific and technological achievements of the department of chemical engineering and the department of automation of tsinghua university. The company is committed to empowering industrial big data technology, industrial intelligent control technology, 5G technology, and AI technology. It can help chemical industry parks and chemical enterprises to help the construction of new infrastructure and industrial Internet in the chemical industry, and promote the intelligent transformation and upgrading of chemical enterprises and the construction of intelligent factories.

HjMicro

Seed Round in 2022
Hongjun Microelectronics is committed to the development of "higher efficiency and easier deployment" server processor (CPU) chips based on the ARM architecture, mainly for the data center cloud computing market.

CSR Biotech

Seed Round in 2022
Guangzhou Chaoshiji Biotechnology Co., Ltd. (Chaoshiji Technologies) is a high-tech company specializing in the creation and deployment of super-resolution imaging devices for living cells. R&D, production, sales, after-sales, and technical output services for various types of super-resolution optical microscopes are the primary activities. Among the services offered are customized cell sample generation, customized cell sample high-throughput detection, customized cell sample imaging studies, and customized image post-processing and quantitative analysis.

ThreatBook

Series E in 2022
Beijing ThreatBook Technology Co., Ltd. is a security company specializing in threat intelligence solutions. Founded in 2015 by Feng Xue, the company is headquartered in Beijing, China. ThreatBook develops a threat detection platform that incorporates threat data, machine learning, and security research. Its product offerings include a threat analysis platform, subscription-based services for threat intelligence, machine-readable threat intelligence, and tools for situational awareness. These solutions are designed to help organizations identify and respond to potential security threats effectively.

Aibo Medical Robot

Seed Round in 2022
Aibo Medical Robot was established in Shenzhen in June 2020, focusing on the vascular interventional surgery robot market. It is reported that behind this "new" company is the accumulation of years of scientific research and technology - that is , the nearly 30 years of research and development accumulation of the founding team.

UniXell

Seed Round in 2022
UniXell develops cell therapies for the treatment of cancer and neurodegenerative disorders.

CYGNUSEMI

Series A in 2022
Cygnus Semi is a semiconductor chip technology company that focuses on 5G IoT applications.

HemaCell

Seed Round in 2022
Xueji Bio is a new cell therapy company founded by returnee experts to regenerate hematopoietic lineages (including blood cells and immune cells) in vitro, with unique stem cell reprogramming, editing and differentiation technologies. The company's unique iPSC establishment technology and gene targeting technology can quickly establish a platform using platelet cells as a drug delivery carrier.

Ai Ma Biology

Angel Round in 2022
Ai Ma Biology is a small RNA nucleic acid drug developer, dedicated to the transformation of achievements in the field of biosynthesis.

Qingyun Zhitong

Series A in 2022
Qingyun Zhitong is an intelligent manufacturing enabling enterprise in the chemical industry. It is a continuous transformation platform for the scientific and technological achievements of the department of chemical engineering and the department of automation of tsinghua university. The company is committed to empowering industrial big data technology, industrial intelligent control technology, 5G technology, and AI technology. It can help chemical industry parks and chemical enterprises to help the construction of new infrastructure and industrial Internet in the chemical industry, and promote the intelligent transformation and upgrading of chemical enterprises and the construction of intelligent factories.

Ceram Pharmaceuticals

Series A in 2022
Ceram Pharmaceuticals is a biotech firm that uses epigenetics to carry out R&D of drugs and diagnostic treatments for cancer and diseases.

Yunli Smart Technology

Series A in 2021
Yunli Zhihui Technology(Cloud Wisdom Technology) is a venture capital firm.

Medical Data System

Venture Round in 2021
Thousand Oaks Biopharmaceuticals, Inc. is a biotechnology company based in Haimen, China, specializing in contract development and manufacturing services for the biopharmaceutical industry. Established in 2017, the company focuses on developing biopharmaceutical technologies that enhance the production of protein and vaccine compounds. It offers integrated control solutions designed to optimize production processes, improve protein expression, and reduce production scale. Additionally, Thousand Oaks provides personalized, chemically-defined cell culture media, formula production, technical support, and ancillary services to its clients. The company also operates a healthcare receivable management platform that enhances patient collections, reduces operational costs, and increases revenue for healthcare providers through effective revenue cycle management and technology-driven solutions.

Qixin Micro Semiconductor

Venture Round in 2021
Suzhou Qixin Micro Semiconductor Co., Ltd. was established in October 2020. Based on the ARM Cortex M4, M7 and other series of architectures, it will build high-performance and high-reliability system-on-chips for different automotive application scenarios, and develop high-end smart car controller chips. Through the use of self-developed IP, unique multi-core lock-step technologies, and the unique Six Sigma analog circuit design process for automotive-standard chips, a full series of product families covering safety standards ISO26262 ASIL-B to ASIL-D have been designed. The company's products all meet the automotive regulations AEC-Q100, functional safety standard ISO26262 and various automotive regulations reliability tests, and can be widely used in the fields of body, automotive instrumentation, safety, power, battery management and other fields. The company is mainly engaged in the research and development and sales of high-end automotive controller chips. The goal is to fill the gap in the domestic new generation of intelligent networked automotive controller chips, and is committed to becoming a leading manufacturer in the field of automotive and industrial controllers in China.

NeoCura

Series A in 2021
NeoCura is a company that specializes in developing AI-based platforms and diagnostic tests for cancer therapy. Founded in 2017 and headquartered in Shenzhen, China, NeoCura offers several advanced tools, including the NeoCura AI ALPINE platform for tumor neoantigen prediction, which identifies potential neoantigen candidates. The NeoCura AI EVEREST platform focuses on validating these neoantigens to enhance patient outcomes. Additionally, NeoCura TP serves as an intelligent companion diagnostic that forecasts treatment options for immunotherapy based on tumor mutational burden. The company also provides an AI-enabled immunotherapy solution that targets patient-specific neoantigens. In addition to these platforms, NeoCura offers diagnostics and medical laboratory services, leveraging AI to improve the diagnosis and treatment of cancer patients.
Core Long March Technology is a high-tech design company specializing in the development of new power semiconductor devices. Its core business includes: coolmos, SiC and other chip products and technology development. The technical team is based on the technical experts of the Chinese Academy of Sciences and the introduction of outstanding overseas technical elites. The core members of the team have more than 6 years of product development experience, and realize the whole chain from chip design, manufacturing process, packaging and testing, reliability and application. The company has a professional marketing and operation management team. It is very familiar with the technology, industry and market in this direction and has good operational capabilities. The technical and management teams have gone through the process from technology development to sample to product to mass production to complete marketization. .

SVOLT

Series B in 2021
Svolt Energy Technology Co., Ltd. is a high-tech new energy company that specializes in energy technology, including electric vehicle battery (EVB) materials, cells, modules, PACK, BMS, energy storage system (ESS) and solar energy R&D and manufacturing. Headquartered in Wuxi, Jiangsu, SVOLT plans for 7 R&D centers around the globe, with four currently in operation, in Baoding, Korea, Shanghai and India, and three are under construction in the US, Japan and Wuxi. Domestically, SVOLT’s factory is under construction in Changzhou, Jiangsu, which will be operational by the end of 2019 with SOP in February 2020, and will have a capacity of 12GWh in 2020. Roadmap: SVOLT is pioneering the introduction of prismatic stacking batteries, making it the world’s first high-speed stacking prismatic battery maker. SVOLT aims to finish stacking one cell in 0.25 seconds in one single station. In contrast to the same type of winding process, the energy density of SVOLT stacking batteries improves 5%, the cycle life improves 10% and the cost reduces 15%.

Vision Medicals

Series D in 2021
Guangzhou Vision Medicals Technology Co., Ltd. specializes in genetic technology and precision medicine, particularly in the realm of pathogen diagnostics. The company develops a range of products aimed at tumor-targeted drug detection, early screening, and accurate identification of pathogens, along with drug resistance genes and virulence factors. Vision Medicals employs advanced technologies, including high-throughput sequencing and CRISPR-based rapid diagnostics, to enhance clinical pathogen detection and reduce reporting times. Additionally, it has created a pathogenic nucleic acid enrichment technology, which has gained recognition for its effectiveness in detecting pathogenic micronucleic acids in clinical samples. By leveraging big data in pathogen detection and employing intelligent genomic analysis, the company significantly contributes to the infection-precise medical industry. Based in Guangzhou, China, Vision Medicals primarily serves pediatric departments in tertiary hospitals.

Changmugu Medical

Series B in 2021
Beijing Changmugu Medical Technology Co., Ltd. is a healthcare start-up that specializes in artificial intelligence solutions for orthopedic procedures. The company focuses on the research and development of AI-assisted diagnostic tools and individualized surgical plans, enhancing the accuracy and safety of orthopedic surgeries. Their offerings include 3D printing patient-specific instrumentation for surgical navigation, as well as post-operative intelligent evaluation services. By leveraging deep learning technologies, Changmugu Medical aims to facilitate safer and more stable operations for patients, ultimately improving outcomes in orthopedic care.

Singleron Biotechnologies

Series B in 2021
Singleron Biotechnologies is a developer and provider of clinical diagnosis, health management and drug development products and services. The company is dedicated to applying single cell analysis techniques and has obtained a world wide exclusive IP license from Yale University for its uniquely designed microfluidic single cell processing device, and has developed the innovative SCOPE single-cell pre-sequencing preparation system based on this microfluidic device.

LaiHua

Series C in 2021
Laihua Digital Co, Ltd. develops and operates a platform that enables users to create and customize videos. Its solutions include hand-drawn video creativity and platform development, hand-drawn video customization and maker education, and professional video services for businesses and individual users. The company was founded in 2015 and is based in Shenzhen, China.

Authing

Series A in 2021
Authing operates a cloud based identity platform for developers and enterprises. It got funded by Plug and Play Ventures, YC China and China Growth Capital. Authing has grown into the leading innovator in the Chinese SaaS market.

IASO Biotherapeutics

Series C in 2021
Nanjing IASO Biotherapeutics is a clinical-stage biotechnology company established in 2017, specializing in the development of innovative therapies for cancer treatment. The company focuses on creating engineered autologous and allogenic T cell therapies aimed at enhancing the immune system's ability to identify and eliminate cancer cells. Its work centers on the discovery, development, and potential commercialization of cell therapies specifically in the oncology sector, striving to advance cancer care through these advanced therapeutic approaches. Based in Nanjing, China, IASO Biotherapeutics is dedicated to addressing the challenges posed by cancer through its targeted treatment solutions.

Mino Space

Series A in 2021
Mino Space is a private commercial satellite company that integrates satellite development and satellite applications. The company is mainly engaged in R&D and manufacturing services of micro-nano satellite systems, independently researching and developing micro-nano satellite platform and core components, possessing satellite star design and integration testing capabilities, and has experience in developing satellite systems such as electronic communication and optical payloads. The ability to coordinate and coordinate the overall situation. The company independently develops satellite terrestrial communication terminals and has experience in satellite communication system integration. It can provide satellite resources-based integrated information system solutions for defense, industry, and regional users. Founded in 2017, Beijing Weina Star Technology Co., Ltd. is located in Yongfeng Industrial Base, Zhongguancun, Beijing.

Petkit

Series D in 2021
Shanghai PETKIT Network Technology Co., Ltd. Develops and manufactures pet care products. It offers smart antibacterial bowls, smart feeders, smart drinking fountains, pet accompanying cups, smart leashes, smart cat brand dog tags, smart pet companions, multifunctional cat claw plates, etc.; cat and dog tags that record, analyze, and track the pet's usual sports behavior data; and toys. Shanghai PETKIT Network Technology Co., Ltd. was founded in 2013 and is based in Shanghai, China.

Qitan Tech

Series B in 2021
Chengdu Qitan Technology Co., Ltd. manufactures fourth generation gene sequencing instrument that uses nanopore gene sequencing technology. The company’s nanopore gene sequencer can be applied to immunophenotyping, for detection of pathogens, and detection of intestinal flora, and detection of tumor genomes based on structural variation. It serves biopharmaceutical, healthcare, and agricultural sectors. The company was founded in 2016 and is based in Chengdu, China.

FXiaoKe

Series F in 2021
FXiaoKe is a Beijing-based company that specializes in cloud-based sales management solutions for Chinese businesses, particularly targeting small and medium-sized enterprises. Established in December 2011 by Luo Xu, the company provides a comprehensive platform that integrates field operation management, distribution chain management, and customer relationship management. FXiaoKe's software enables businesses to enhance their sales processes through a social interaction platform that merges features of dynamic customer relationship management with capabilities akin to enterprise WeChat. The platform supports collaboration across various sectors, including high-tech industries, corporate services, fast-moving consumer goods, agriculture, and large-scale manufacturing, facilitating efficient marketing, sales, and service operations. Additionally, FXiaoKe offers online office automation services that allow seamless information sharing between personal computers and smartphones, further enhancing customer management.
Elpiscience Biopharmaceuticals Co., Ltd. operates as an immunology company that develops immunotherapies to treat cancer. The company is based in Pudong, China with an additional office in Suzhou, China.

OakMega

Series A in 2021
OakMega is a provider of cross-platform CRM solutions on messaging apps for marketing experts. Driven by honest values, and win-win mentality in their culture, OakMega is out to connect brands and people with human touch.

Chunmi Technology

Series D in 2021
Shanghai Chunmi Electronic Technology Co., Ltd. manufactures kitchen appliances. The company manufactures induction rice cooker. Shanghai Chunmi Electronic Technology Co., Ltd. was founded in 2013 and is based in Shanghai, China.

Nice Tuan

Private Equity Round in 2021
Nice Tuan is an e-commerce platform that specializes in providing daily groceries and a variety of household products. The company collaborates with local residential communities to source items from nearby warehouses and producers, ensuring a wide selection of fresh produce and essential goods for residents. By focusing on creating a convenient and efficient community e-commerce ecosystem, Nice Tuan aims to enhance the shopping experience for local consumers while supporting local suppliers.

ForwardX Robotics

Series B in 2021
ForwardX Robotics, Inc. is a technology company specializing in artificial intelligence and robotics, with a focus on developing innovative solutions for logistics and manufacturing sectors. Founded in 2016 and headquartered in Beijing, China, the company also has offices in San Diego and Phoenix, United States. ForwardX is recognized for its mobile robotics vision-powered products, including a side-follow suitcase called Ovis, which integrates GPS and 3G technology for tracking. The company holds over 160 pending patents and employs a team of more than 180 professionals, including 120 engineers, many of whom are top experts in computer vision and robotics. ForwardX's offerings, including Autonomous Mobile Robots and Fleet Manager, are designed to improve operational efficiency and address challenges such as rising labor costs and productivity issues within the industry.

Medical Data System

Series C in 2021
Thousand Oaks Biopharmaceuticals, Inc. is a biotechnology company based in Haimen, China, specializing in contract development and manufacturing services for the biopharmaceutical industry. Established in 2017, the company focuses on developing biopharmaceutical technologies that enhance the production of protein and vaccine compounds. It offers integrated control solutions designed to optimize production processes, improve protein expression, and reduce production scale. Additionally, Thousand Oaks provides personalized, chemically-defined cell culture media, formula production, technical support, and ancillary services to its clients. The company also operates a healthcare receivable management platform that enhances patient collections, reduces operational costs, and increases revenue for healthcare providers through effective revenue cycle management and technology-driven solutions.

Vision Medicals

Series C in 2021
Guangzhou Vision Medicals Technology Co., Ltd. specializes in genetic technology and precision medicine, particularly in the realm of pathogen diagnostics. The company develops a range of products aimed at tumor-targeted drug detection, early screening, and accurate identification of pathogens, along with drug resistance genes and virulence factors. Vision Medicals employs advanced technologies, including high-throughput sequencing and CRISPR-based rapid diagnostics, to enhance clinical pathogen detection and reduce reporting times. Additionally, it has created a pathogenic nucleic acid enrichment technology, which has gained recognition for its effectiveness in detecting pathogenic micronucleic acids in clinical samples. By leveraging big data in pathogen detection and employing intelligent genomic analysis, the company significantly contributes to the infection-precise medical industry. Based in Guangzhou, China, Vision Medicals primarily serves pediatric departments in tertiary hospitals.

Babycare

Series B in 2021
Babycare is an e-commerce platform providing products for new parents and children. The company specializes in the design, research, and development of mother-baby products. Its products are based on recommendations by a series of research and experiments regarding orthopedic development of babies. One of its products is the infant waist carrier, which is crafted to improve the comfortability of infants and prevent from bowleg posturing which hinders blood circulation. The company is committed to achieving the aspiration of being product designers and baby caretakers. The company was founded in 2014 and is headquartered in Shanghai, China.

CYGNUSEMI

Seed Round in 2021
Cygnus Semi is a semiconductor chip technology company that focuses on 5G IoT applications.

GenFleet Therapeutics

Venture Round in 2021
GenFleet Therapeutics, based in Shanghai, China, is a biotechnology company focused on the research and development of therapeutic molecules aimed at cancer treatment. Founded in 2017, the company specializes in creating innovative pharmaceuticals and antibody drugs that target various cancer systems. Its efforts are directed at reactivating tumor-specific immune responses and mobilizing the body's own immune system to combat cancer. GenFleet Therapeutics serves both domestic and international markets, contributing to advancements in cancer therapy through its development of signal transduction regulators, tumor microenvironment modulators, and transcription factors.

JLSemi

Series B in 2020
JLSemi specializes and excels in high-speed Analog, advanced DSP, and mixed-signal designs. JLSemi is pushing the boundary of Ethernet technology. Innovations in silicon architecture & design coupled with advanced process nodes, its products deliver industry-leading performance in range, resilience, and power consumption.

Nice Tuan

Series C in 2020
Nice Tuan is an e-commerce platform that specializes in providing daily groceries and a variety of household products. The company collaborates with local residential communities to source items from nearby warehouses and producers, ensuring a wide selection of fresh produce and essential goods for residents. By focusing on creating a convenient and efficient community e-commerce ecosystem, Nice Tuan aims to enhance the shopping experience for local consumers while supporting local suppliers.

Virogin Biotech

Series C in 2020
Virogin Biotech Ltd. ("Virogin") was founded in 2015, with the headquarters located in Vancouver, Canada. They are dedicated to developing the next generation of oncolytic virus (OV) therapeutics using their novel Synerlytic™ technical platform for improved cancer treatment. By exploring innovative approaches to immunotherapy, Virogin is committed to becoming a world leader in the field of immuno-oncology.

Creative Biosciences

Series C in 2020
Kang Liming Bio is a biomedical technology company that specializes in the development, production and sales of tumor screening diagnostic products such as colorectal cancer fecal non-invasive screening kits.

Virogin Biotech

Series C in 2020
Virogin Biotech Ltd. ("Virogin") was founded in 2015, with the headquarters located in Vancouver, Canada. They are dedicated to developing the next generation of oncolytic virus (OV) therapeutics using their novel Synerlytic™ technical platform for improved cancer treatment. By exploring innovative approaches to immunotherapy, Virogin is committed to becoming a world leader in the field of immuno-oncology.

Singleron Biotechnologies

Series A in 2020
Singleron Biotechnologies is a developer and provider of clinical diagnosis, health management and drug development products and services. The company is dedicated to applying single cell analysis techniques and has obtained a world wide exclusive IP license from Yale University for its uniquely designed microfluidic single cell processing device, and has developed the innovative SCOPE single-cell pre-sequencing preparation system based on this microfluidic device.

Vision Medicals

Series B in 2020
Guangzhou Vision Medicals Technology Co., Ltd. specializes in genetic technology and precision medicine, particularly in the realm of pathogen diagnostics. The company develops a range of products aimed at tumor-targeted drug detection, early screening, and accurate identification of pathogens, along with drug resistance genes and virulence factors. Vision Medicals employs advanced technologies, including high-throughput sequencing and CRISPR-based rapid diagnostics, to enhance clinical pathogen detection and reduce reporting times. Additionally, it has created a pathogenic nucleic acid enrichment technology, which has gained recognition for its effectiveness in detecting pathogenic micronucleic acids in clinical samples. By leveraging big data in pathogen detection and employing intelligent genomic analysis, the company significantly contributes to the infection-precise medical industry. Based in Guangzhou, China, Vision Medicals primarily serves pediatric departments in tertiary hospitals.

Nice Tuan

Series C in 2020
Nice Tuan is an e-commerce platform that specializes in providing daily groceries and a variety of household products. The company collaborates with local residential communities to source items from nearby warehouses and producers, ensuring a wide selection of fresh produce and essential goods for residents. By focusing on creating a convenient and efficient community e-commerce ecosystem, Nice Tuan aims to enhance the shopping experience for local consumers while supporting local suppliers.
Shanghai Mission Information Technology Co., Ltd. provides information technology consulting, design, development, integration, and maintenance services for building, operation, maintenance, and management of the public transportation systems. The company offers mechanical electronic system and information management, metro network operation management platform, metro network maintenance management platform, passenger guide signage, building automation system, and transportation system solutions. It serves metros, light rail transits, large transportation hubs, high-speed railways, airports, and other transportation means. Shanghai Mission Information Technology Co., Ltd. was founded in 2018 and is based in Shanghai, China.

WowTech

Private Equity Round in 2020
WOW Tech Group is one of the world's leading companies in the pleasure product market. With our innovative and high-quality brands Womanizer® and We-Vibe® we delight millions of customers and help them to have a more fulfilling sex life. WOW Tech Group brands We-Vibe® and Womanizer® are available at thousands of retail locations in over 60 countries around the world.

GenFleet Therapeutics

Series B in 2020
GenFleet Therapeutics, based in Shanghai, China, is a biotechnology company focused on the research and development of therapeutic molecules aimed at cancer treatment. Founded in 2017, the company specializes in creating innovative pharmaceuticals and antibody drugs that target various cancer systems. Its efforts are directed at reactivating tumor-specific immune responses and mobilizing the body's own immune system to combat cancer. GenFleet Therapeutics serves both domestic and international markets, contributing to advancements in cancer therapy through its development of signal transduction regulators, tumor microenvironment modulators, and transcription factors.

Teld New Energy

Series A in 2020
Shanghai Teld New Energy Co., Ltd. is headquartered in China. The company operates as a subsidiary of Qingdao Teld New Energy Co., Ltd.
Elpiscience Biopharmaceuticals Co., Ltd. operates as an immunology company that develops immunotherapies to treat cancer. The company is based in Pudong, China with an additional office in Suzhou, China.

Teld New Energy

Venture Round in 2019
Shanghai Teld New Energy Co., Ltd. is headquartered in China. The company operates as a subsidiary of Qingdao Teld New Energy Co., Ltd.

Micro language

Series B in 2019
Microlanguage is a Beijing-based online English learning platform. Microlanguage is a platform which enable students to learn a foreign language via online classes. It also allow students to pick their teachers and fix their own schedules.

Golden Technology

Series B in 2019
Golden Technology is a big data service company offering electronic invoice solutions using blockchain technology.

Fapiaoer

Series B in 2019
Fapiaoer is a Chinese electronic invoicing service provider under Tencent-backed Chinese project incubator and group-buying platform GaoPeng. Based on a variety of business success stories, with a strong operating, technical, product team, Gao Peng internal restructuring team to provide electronic invoicing services in an effort to create the most convenient and most reasonable electronic invoice preparation, preservation, and reimbursement experience for users. , Tencent and U.S. GROUPON Each group invested 50 million U.S. dollars to develop a group purchasing business company to become: Wechat commercialization project incubation platform, Tencent eco-layout early investment platform, Group purchasing model integration optimization of new e-commerce platform and other three business lines go hand in hand with diversified technology The company, currently Tencent, is the single largest shareholder of Gao Peng.

Benlai

Series D in 2019
Beijing Benlai Workshop Technology Co., Ltd. sells vegetables and fruits through online platform in China. It provides products, such as meats, poultry products, seafood, dairy products, snacks, cooked noodles, grain and oil non staples, beverages, and kitchen supplies. The company also operates additional warehouses in Beijing, Shanghai, and Guangzhou, China; and temperature controlled logistics supply centers throughout China. Beijing Benlai Workshop Technology Co., Ltd. was founded in 2012 and is headquartered in Beijing, China.

Learnroom Kindergarten

Series A in 2019
Learnroom Kindergarten is an integrated institution for early childhood education and child care. It provides a one-stop comprehensive service for members of children aged 0-6 and their families. Its core services include three business segments: 0-3 years old parent-child early education, 0-3 years old childcare service and 3-6 years old quality education.

Ruigu

Series C in 2019
Founded in 2013, Ruigu is an e-commerce platform focused on the Chinese electrical hardware sector.

Jiayouxueba

Series C in 2019
The core product of Homeschooling is online in March 2016. The client includes PC, WEB and mobile APP. The platform ensures the optimization of teachers and teaching quality through rigorous screening, and the teacher-centered operation connects students with different teachers in various subjects. While the school has a high income for the teacher, it also solves the needs of students' fragmentation and efficient learning, so that users at the income end and the supply end are rooted in the platform. At home, Xueba has covered 1 pair 1, small classes, and large classes. It is expected to achieve a single monthly profit in the second half of the year.

GemPharmatech

Series A in 2019
GemPharmatech Co., Ltd. is a biotechnology company based in Nanjing, China, founded in 2017. It specializes in developing gene-modified mouse models and providing preclinical services to the biomedical community and pharmaceutical companies. The company offers a range of services, including immune system efficacy studies, tumor transplantation, and phenotyping. Additionally, it creates various animal models such as humanized mice, disease models, and genetically modified rats using advanced techniques like CRISPR/Cas9 and ES Cell Microinjection. In 2018, GemPharmatech established its "Humanization Model and Drug Screening Innovation Technology Research Institute," which was integrated into the Jiangsu Industrial Technology Research Institute, enhancing its research capabilities. The company aims to support global partners with innovative technologies and comprehensive resources, including model creation, breeding, mouse sales, phenotypic analysis, and functional efficacy assessments.

GemPharmatech

Series A in 2019
GemPharmatech Co., Ltd. is a biotechnology company based in Nanjing, China, founded in 2017. It specializes in developing gene-modified mouse models and providing preclinical services to the biomedical community and pharmaceutical companies. The company offers a range of services, including immune system efficacy studies, tumor transplantation, and phenotyping. Additionally, it creates various animal models such as humanized mice, disease models, and genetically modified rats using advanced techniques like CRISPR/Cas9 and ES Cell Microinjection. In 2018, GemPharmatech established its "Humanization Model and Drug Screening Innovation Technology Research Institute," which was integrated into the Jiangsu Industrial Technology Research Institute, enhancing its research capabilities. The company aims to support global partners with innovative technologies and comprehensive resources, including model creation, breeding, mouse sales, phenotypic analysis, and functional efficacy assessments.

iStar-Space Technology

Seed Round in 2019
iStar-Space Technology is committed to the innovation and application of aerospace technology. It has a leading domestic technical level in the advanced structure of aircraft, institutional design, intelligent composite material research and development and manufacturing processes. AiSida Aerospace Technology focuses on providing partners with advanced technology, reliable quality, cost-optimized structural research and development and production services, providing professional advanced structure and rapid development of institutional solutions and components.

Creative Biosciences

Series B in 2019
Kang Liming Bio is a biomedical technology company that specializes in the development, production and sales of tumor screening diagnostic products such as colorectal cancer fecal non-invasive screening kits.

Jiayouxueba

Series B in 2019
The core product of Homeschooling is online in March 2016. The client includes PC, WEB and mobile APP. The platform ensures the optimization of teachers and teaching quality through rigorous screening, and the teacher-centered operation connects students with different teachers in various subjects. While the school has a high income for the teacher, it also solves the needs of students' fragmentation and efficient learning, so that users at the income end and the supply end are rooted in the platform. At home, Xueba has covered 1 pair 1, small classes, and large classes. It is expected to achieve a single monthly profit in the second half of the year.

DMAI

Venture Round in 2019
DMAI (Guangzhou) Co., Ltd. provides a cognitive artificial intelligence platform to realize machine-to-human communication and collaboration. The company's artificial intelligence technology platform unifies and integrates six areas of computer vision, cognitive science, language dialogue, machine learning, robotics, and game ethics. It serves to education, healthcare, gaming, smart driving, personal assistants, and smart robotics sectors. The company is based in China.

ForwardX Robotics

Series B in 2019
ForwardX Robotics, Inc. is a technology company specializing in artificial intelligence and robotics, with a focus on developing innovative solutions for logistics and manufacturing sectors. Founded in 2016 and headquartered in Beijing, China, the company also has offices in San Diego and Phoenix, United States. ForwardX is recognized for its mobile robotics vision-powered products, including a side-follow suitcase called Ovis, which integrates GPS and 3G technology for tracking. The company holds over 160 pending patents and employs a team of more than 180 professionals, including 120 engineers, many of whom are top experts in computer vision and robotics. ForwardX's offerings, including Autonomous Mobile Robots and Fleet Manager, are designed to improve operational efficiency and address challenges such as rising labor costs and productivity issues within the industry.

Mengmei

Series A in 2019
Mengmei is a medical service organization founded by 6 doctors of American Dream Beauty HRC. The only authorized American IVF service provider in China does not charge any fees. HRC has nine hospitals, three laboratories, and American test tubes. The baby success rate ranked first (US CDC data publicity), providing free exit support for domestic customers, booking expert video consultation, visa processing and doctor docking, accommodation arrangements and other issues in the United States.

Eyoule.com

Series B in 2019
Eyoule.com is a supply chain service platform for catering industry.

Mushiny

Series A in 2019
Suzhou Mushiny Intelligence Technology Co., LTD. specializes in designing and developing warehouse management systems (WMS) and intelligent logistics solutions. Its flagship product, the Mushiny Robot Warehouse Management System (MRWMS), integrates hardware and software components, including robots, picking stations, and network equipment, to optimize warehouse operations. Additionally, the company offers the Mushiny Intelligence System (MIS), which addresses traditional manual warehouse processes, and an Order Fulfillment System. Leveraging advanced algorithms, Mushiny provides comprehensive solutions tailored to the warehousing industry, including project design, consultation, systems integration, and implementation. With a team experienced in e-commerce and manufacturing, Mushiny aims to enhance operational efficiency for various industries through its innovative warehousing technologies, particularly in the realm of smart logistics. The company is headquartered in Suzhou, China.

Micro language

Series A in 2019
Microlanguage is a Beijing-based online English learning platform. Microlanguage is a platform which enable students to learn a foreign language via online classes. It also allow students to pick their teachers and fix their own schedules.

iSpace China

Series A in 2019
iSpace China develops commercial launch vehicles to commercial aerospace customers worldwide. The company was founded in 2016 and is based in Beijing, China.

Medbanks

Series D in 2018
Medbanks Network Technology Co. Ltd. provides data processing services to healthcare industry. The company develops multi center database that manages and mines data that reflects China's patient population. Medbanks Network Technology Co. Ltd. was founded in 2014 and is based in Beijing, China.

Infervision

Series C in 2018
Infervision is an artificial intelligence company based in Beijing that specializes in enhancing medical imaging diagnosis through deep learning and computer vision technologies. The company focuses on developing clinically valuable products aimed at improving the accuracy and efficiency of cancer diagnosis. Infervision has introduced innovative solutions such as the world's first artificial intelligence precise healthcare platform, along with intelligent X-ray and CT diagnostic products, which are currently undergoing trials at several prominent hospitals in China. The company collaborates closely with top institutions in radiology, fostering a strong relationship between medical science and technology. Infervision has partnered with approximately 20 leading hospitals, successfully integrating medical data and technology to advance healthcare solutions. By creating a unique artificial intelligence computing platform, Infervision aims to facilitate precise healthcare and improve diagnostic outcomes for medical professionals.
Elpiscience Biopharmaceuticals Co., Ltd. operates as an immunology company that develops immunotherapies to treat cancer. The company is based in Pudong, China with an additional office in Suzhou, China.

Precision Intelligence

Series A in 2018
Precision Intelligence is a Healthcare company.

Longzhimen Education

Series A in 2018
Longzhimen Education= is an education Platform.

Mr. Zebra

Angel Round in 2018
Mr. Zebra is a Chinese education company that specializes in teaching Chinese children between the ages of 3 and 6.

Chargerlink

Series A in 2018
Chargerlink Inc. specializes in developing charging station solutions for the electric vehicle (EV) sector. Founded in 2014 and based in Shenzhen, China, the company collaborates with major EV manufacturers, including Tesla, BMW, Nissan, and BYD, as well as operators and manufacturers of charging stations. Chargerlink is also looking to expand its offerings into location-based services, aiming to provide additional opportunities for EV owners during the charging process.

SmartIRSEC

Seed Round in 2018
SmartIRSEC, founded in 2016 and based in Beijing, China, specializes in the manufacturing of security system equipment. As a smart hardware company, SmartIRSEC focuses on developing advanced technological solutions aimed at enhancing security and safety. The company combines innovative design with practical functionality to meet the growing demands of the security industry. Through its products, SmartIRSEC aims to provide reliable and efficient security solutions for various applications.

SmartIRSEC

Seed Round in 2018
SmartIRSEC, founded in 2016 and based in Beijing, China, specializes in the manufacturing of security system equipment. As a smart hardware company, SmartIRSEC focuses on developing advanced technological solutions aimed at enhancing security and safety. The company combines innovative design with practical functionality to meet the growing demands of the security industry. Through its products, SmartIRSEC aims to provide reliable and efficient security solutions for various applications.

TMiRob

Series B in 2018
TMiRob is a developer of medical robots aimed at enhancing operational efficiency in hospitals and clinics. The company's robots assist in various aspects of medical treatment and nursing services, including the management of high-value consumables, delivery of infusion packages, instrument distribution, and intelligent medicine cabinet management. Additionally, TMiRob's solutions facilitate the disposal of medical waste, contributing to cost savings and improved management for healthcare facilities. Through these innovations, TMiRob supports medical workers by streamlining processes and enhancing the overall quality of care provided in healthcare settings.

I-Mab HK

Series C in 2018
I-Mab HK develops drugs to treat diabetes, cancer, and autoimmune diseases. The company develops preclinical compounds, including GX-P2; a long-acting PD-L1 drug for the treatment of inflammatory bowel diseases and GX-G8; a long-acting GLP-2 drug for the treatment of chemotherapy-induced diarrhea and short bowel syndrome. The company was formerly known as Tianzhenshi Biotechnology Company and changed its name to I-Mab HK in March 2017. The company is headquartered in Tianjin, China.

I-Mab HK

Series C in 2018
I-Mab HK develops drugs to treat diabetes, cancer, and autoimmune diseases. The company develops preclinical compounds, including GX-P2; a long-acting PD-L1 drug for the treatment of inflammatory bowel diseases and GX-G8; a long-acting GLP-2 drug for the treatment of chemotherapy-induced diarrhea and short bowel syndrome. The company was formerly known as Tianzhenshi Biotechnology Company and changed its name to I-Mab HK in March 2017. The company is headquartered in Tianjin, China.

ZTO Freight

Series A in 2018
ZTO Supply Chain Management Co., Ltd. is a logistics management company established in 2016, headquartered in Jiaxing, China. The company specializes in providing comprehensive logistics solutions, focusing on optimizing supply chain processes for its clients. ZTO Freight aims to enhance efficiency and reliability in the transportation of goods, catering to a wide range of industries. Its services include freight management, warehousing, and distribution, positioning the company as a key player in the logistics sector within China and beyond.

ForwardX Robotics

Series A in 2018
ForwardX Robotics, Inc. is a technology company specializing in artificial intelligence and robotics, with a focus on developing innovative solutions for logistics and manufacturing sectors. Founded in 2016 and headquartered in Beijing, China, the company also has offices in San Diego and Phoenix, United States. ForwardX is recognized for its mobile robotics vision-powered products, including a side-follow suitcase called Ovis, which integrates GPS and 3G technology for tracking. The company holds over 160 pending patents and employs a team of more than 180 professionals, including 120 engineers, many of whom are top experts in computer vision and robotics. ForwardX's offerings, including Autonomous Mobile Robots and Fleet Manager, are designed to improve operational efficiency and address challenges such as rising labor costs and productivity issues within the industry.

HitGen

Series B in 2018
HitGen Inc. is a biotechnology company specializing in early-stage drug discovery through its innovative platform that utilizes DNA encoded chemical libraries (DELs). The company develops diverse drug-like small molecules and macrocycle compounds and is engaged in several internal research projects across various therapeutic areas, including oncology, cardiovascular diseases, inflammation, metabolism, and ophthalmology. HitGen collaborates with renowned organizations such as Gilead Sciences, Galapagos NV, Kymera Therapeutics, and Morphic Therapeutic to discover potential small molecule leads. Additionally, it has formed a strategic partnership with Oncodesign Société Anonyme for the identification and advancement of new chemical entities. Founded in 2012, HitGen is headquartered in Chengdu, China.

SITECH DEV

Series A in 2018
SITECH DEV is an important part of China's first new energy vehicle industry chain that is being built in Gui'an New Area. After signing with China FAW, the two parties will use Gui'an New Area as the intelligent data advantage of the National Big Data Center and commit to intelligence. The electric, shared travel product development, manufacturing and service ecosystem accelerates this exciting smart travel strategy. Signed an A-round financing framework agreement with top domestic investment institutions, and reached a strategic cooperation with international auto supply chain giant Bosch to establish a trend alliance advocated by Xinte Auto.

Jollychic

Series C in 2018
Jollychic EC Limited is an online retail platform that offers a diverse range of products, including clothing, shoes, bags, baby items, electronics, home goods, and various accessories. Established in 2012 and headquartered in Birkirkara, Malta, Jollychic aims to provide customers with a convenient shopping experience through its extensive selection of stylish and quality products. The platform features categories such as apparel, sports goods, toys, bedding, wedding supplies, cleaning tools, and kitchen appliances, making it a comprehensive destination for consumers seeking a variety of goods in one place.

HitGen

Series B in 2018
HitGen Inc. is a biotechnology company specializing in early-stage drug discovery through its innovative platform that utilizes DNA encoded chemical libraries (DELs). The company develops diverse drug-like small molecules and macrocycle compounds and is engaged in several internal research projects across various therapeutic areas, including oncology, cardiovascular diseases, inflammation, metabolism, and ophthalmology. HitGen collaborates with renowned organizations such as Gilead Sciences, Galapagos NV, Kymera Therapeutics, and Morphic Therapeutic to discover potential small molecule leads. Additionally, it has formed a strategic partnership with Oncodesign Société Anonyme for the identification and advancement of new chemical entities. Founded in 2012, HitGen is headquartered in Chengdu, China.